Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evoke Pharma (EVOK) Debt Ratio (2020 - 2023)

Historic Debt Ratio for Evoke Pharma (EVOK) over the last 4 years, with Q4 2023 value amounting to 0.71.

  • Evoke Pharma's Debt Ratio rose 6766.51% to 0.71 in Q4 2023 from the same period last year, while for Dec 2023 it was 0.71, marking a year-over-year increase of 6766.51%. This contributed to the annual value of 0.71 for FY2023, which is 6766.51% up from last year.
  • Per Evoke Pharma's latest filing, its Debt Ratio stood at 0.71 for Q4 2023, which was up 6766.51% from 0.64 recorded in Q3 2023.
  • Over the past 5 years, Evoke Pharma's Debt Ratio peaked at 0.71 during Q4 2023, and registered a low of 0.64 during Q3 2023.
  • Over the past 4 years, Evoke Pharma's median Debt Ratio value was 0.37 (recorded in 2022), while the average stood at 0.28.
  • Per our database at Business Quant, Evoke Pharma's Debt Ratio skyrocketed by 11377.55% in 2022 and then plummeted by 27077.0% in 2023.
  • Quarter analysis of 4 years shows Evoke Pharma's Debt Ratio stood at 0.53 in 2020, then decreased by 10.77% to 0.47 in 2021, then fell by 10.79% to 0.42 in 2022, then soared by 67.67% to 0.71 in 2023.
  • Its Debt Ratio was 0.71 in Q4 2023, compared to 0.64 in Q3 2023 and 0.56 in Q2 2023.